These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 3065098)

  • 1. Hypertension therapy: current and future strategies.
    Pardell H
    J Int Med Res; 1988; 16 Suppl 1():2A-7A. PubMed ID: 3065098
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Retrospective studies and prospects of therapy for hypertension].
    Maisch B; Brilla C; Kruse T; Noll B; Bethge C
    Herz; 1995 Dec; 20(6):370-89. PubMed ID: 8582697
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The future of antihypertensive treatment.
    Israili ZH; Hernández-Hernández R; Valasco M
    Am J Ther; 2007; 14(2):121-34. PubMed ID: 17414579
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Antihypertensive therapy and prevention of hypertensive complications].
    Kiowski W; Bühler FR
    Schweiz Rundsch Med Prax; 1990 Sep; 79(39):1125-31. PubMed ID: 2218248
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Calcium antagonists in cardiovascular disease. Clinical evidence from morbidity and mortality trials].
    Oparil S; Bakir SE
    Drugs; 2000; 59 Spec No 2():25-37. PubMed ID: 11002856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiovascular events in elderly patients with isolated systolic hypertension. A subgroup analysis of treatment strategies in STOP-Hypertension-2.
    Ekbom T; Linjer E; Hedner T; Lanke J; De Faire U; Wester PO; Dahlöf B; Scherstén B
    Blood Press; 2004; 13(3):137-41. PubMed ID: 15223721
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Left ventricular hypertrophy: how to influence an important risk factor in hypertension.
    Agabiti-Rosei E; Muiesan ML
    J Hypertens Suppl; 1998 Jan; 16(1):S53-8. PubMed ID: 9534098
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Treatment of arterial hypertension in the elderly person: unresolved problems].
    Scherrer U
    Schweiz Rundsch Med Prax; 1990 Aug; 79(35):993-5. PubMed ID: 2218220
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ESH-ESC guidelines for the management of hypertension.
    Erdine S; Ari O; Zanchetti A; Cifkova R; Fagard R; Kjeldsen S; Mancia G; Poulter N; Rahn KH; Rodicio JL; Ruilope LM; Staessen J; van Zwieten P; Waeber B; Williams B
    Herz; 2006 Jun; 31(4):331-8. PubMed ID: 16810473
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Losartan Intervention For Endpoint reduction (LIFE) in Hypertension study: rationale, design, and methods. The LIFE Study Group.
    Dahlöf B; Devereux R; de Faire U; Fyhrquist F; Hedner T; Ibsen H; Julius S; Kjeldsen S; Kristianson K; Lederballe-Pedersen O; Lindholm LH; Nieminen MS; Omvik P; Oparil S; Wedel H
    Am J Hypertens; 1997 Jul; 10(7 Pt 1):705-13. PubMed ID: 9234823
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk stratification for the prevention of cardiovascular complications of hypertension.
    Girerd X; Giral P
    Curr Med Res Opin; 2004 Jul; 20(7):1137-42. PubMed ID: 15265258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Actual blood pressure control: are we doing things right?
    Coca A
    J Hypertens Suppl; 1998 Jan; 16(1):S45-51. PubMed ID: 9534097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Total cardiovascular risk: a new treatment concept.
    Mancia G
    J Hypertens Suppl; 2006 Apr; 24(2):S17-24. PubMed ID: 16601556
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of losartan versus atenolol on cardiovascular morbidity and mortality in patients with hypertension and ECG-verified left ventricular hypertrophy in the LIFE-study].
    Ibsen H; Pedersen OL; Dahlöf B; Kjeldsen SE; Lindholm LH
    Ugeskr Laeger; 2003 Jan; 165(5):456-9. PubMed ID: 12599843
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [New therapeutic outlooks in the treatment of the hypertensive patient].
    Ambrosioni E; Bacchelli S; Borghi C
    Ann Ital Med Int; 1995 Oct; 10 Suppl():78S-81S. PubMed ID: 8562273
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antihypertensive drugs and the heart.
    Diamond JA; Phillips RA
    Minerva Med; 2005 Aug; 96(4):247-60. PubMed ID: 16179892
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated cardiovascular risk management for the future: lessons learned from the ASCOT trial.
    Volpe M; Tocci G
    Aging Clin Exp Res; 2005 Aug; 17(4 Suppl):46-53. PubMed ID: 16640173
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Hypertension and cardiovascular damage].
    Zanchetti A
    Ann Ital Med Int; 1992; 7(3 Suppl):97S-99S. PubMed ID: 1297404
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Arterial hypertension: current large therapeutic trials].
    Chalon S; Brudi P; Lechat P
    Therapie; 1996; 51(6):631-8. PubMed ID: 9163999
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Five decades of antihypertensive treatment: the unresolved issues.
    Julius S
    J Hypertens Suppl; 2000 Jul; 18(3):S3-7. PubMed ID: 10952081
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.